How to avoid late stage attrition rates when developing #orphandrugs
Innovation of orphan drugs to treat rare diseases is essential as the available treatment:rare disease ratio remains against the patients in..
Featured News - Catalyst
-
Kenta Biotech takes on #pneumonia -
Getting high with #MultipleSclerosis patients -
NORD honors advocates of #RareDisease patients
 |
Kenta Biotech takes on #pneumoniaNew orphan drug from Kenta Biotech will help fight pneumonia Read the original article here In recent years, health care professionals have been experiencing more and more difficulty effectively treating.. |
 |
Getting high with #MultipleSclerosis patientsResearchers at the University of California find more positive benefits of marijuana Read the original article here Jody Corey-Bloom, MD, PhD of the Multiple Sclerosis Center at the University of California.. |
 |
NORD honors advocates of #RareDisease patientsNORD celebrates those who have made a difference in the lives of rare disease patients Read the original article here This Tuesday, May 15, the National Organization for Rare Disorders will hold the awards.. |
What are the challenges when translating rare disease research into clinical development?
6000-8000 rare diseases. A very small percentage of orphan drugs to treat. There is still so long to go and so much research to be done in the..
Common mistakes to avoid during late stage #orphandrug development
Orphan drug development suffers from high late stage attrition rates, a challenge stifling all of pharmaceutical innovation. Experience goes..
What are the benefits of adaptive clinical trial design for your #orphandrug? #rarediseases
Adaptive clinical trial design is increasingly becoming the buzzword for successful clinical development of your orphan drug. We surveyed and..
What are the major challenges for #orphandrug clinical trial design? #raredisease
Orphan drug development to treat rare diseases has be proposed as an indication of pharmaceutical innovation in Europe. Moreover, successfully..
Rare disease patient groups – Saving Case at World Orphan Drug Congress USA
Melissa Hogan of Saving Case kindly provided this guest blog post. Melissa attended this year’s World Orphan Drug Congress USA, and presented..
Takeaways from the World Orphan Drug Congress USA – by Siren Interactive
Siren Interactive kindly provided this guest blog post from their blog, SirenSong. It was written by Eileen O’Brien, Director of Search &..
for archived posts, see Categories
